Shares in biotechnology, life sciences, and diagnostics company Danaher (NYSE: DHR) rose by as much as 12.9% in early morning ...

It is financial reporting season, and a few major medtech companies posted third-quarter sales growth. | It is financial ...

Discover Danaher Q3 2025 earnings call insights—revenue growth, margin expansion, and 2026 targets. Get key financial and market outlook.

Danaher stock surged over 7% on Tuesday after the company delivered a solid third-quarter performance, with revenues rising 4 ...

Danaher Corporation ( NYSE: DHR) Q3 2025 Earnings Call October 21, 2025 8:00 AM EDT ...

Danaher Corp (DHR) reports robust Q3 performance with $6.1 billion in sales, a 10% increase in adjusted EPS, and a $2 billion ...

Diversified science and technology company Danaher (NYSE:DHR) reported revenue ahead of Wall Street’s expectations in Q3 ...